Michael F Concino

USPTO Granted Patents = 27 (Patent Applications = 7)

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 12 (Patent Applications = 14)

Average Co-Inventor Count = 4.2

ph-index = 9

Forward Citations = 381(Granted Patents)

Location History:

Newton, MA (US) (1993 - 2005)
Lexington, MA (US) (2020)
Bolton, MA (US) (2007 - 2021)

Company Filing History:

15 out of 86

Shire Human Genetic Therapies, Inc.

patents

5 out of 3,687

Johns Hopkins University

patents

5 out of 1,373

The Brigham and Women's Hospital, Inc.

patents

4. 4 out of 24

T Cell Sciences, Inc.

patents

5. 4 out of 40

Transkaryotic Therapies, Inc.

patents

6. 2 out of 20

Avant Immunotherapeutics, Inc.

patents

7. 1 out of 25

Synageva Biopharma Corporation

where one patent can have more than one assignee

Years Active: 1993-2021

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11065307 - Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety (2021-07-20),

2. 10729746 - Recombinant placenta growth factor for treating Duchenne muscular dystrophy (2020-08-04),

3. 10722559 - Mannose-6-phosphate bearing peptides fused to lysosomal enzymes (2020-07-28),

4. 10603364 - Lysosomal targeting and uses thereof (2020-03-31),

5. 10556015 - Lysosomal targeting of enzymes, and uses thereof (2020-02-11),

6. 9932568 - Peptide linkers for polypeptide compositions and methods for using same (2018-04-03),

7. 9932377 - Mitochondrial targeting and therapeutic use thereof (2018-04-03),

8. 9814764 - Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase (2017-11-14),

9. 9708590 - Crystal structure of human α-N-acetylglucosaminidase (2017-07-18),

10. 9597376 - Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis (2017-03-21),

11. 9453847 - Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereof (2016-09-27),

12. 9260495 - Mitochondrial targeting and therapeutic use thereof (2016-02-16),

13. 9206235 - Peptide linkers for polypeptide compositions and methods for using same (2015-12-08),

14. 8945542 - Methods for treating lysosomal acid lipase deficiency (2015-02-03),

15. 8775146 - Crystal structure of human alpha-N-acetylglucosaminidase (2014-07-08),

Title: The Innovative Journey of Michael F Concino

Introduction: Michael F Concino, a talented inventor hailing from Bolton, MA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Michael F Concino holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights: With a career spanning over two decades, Michael F Concino has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Michael F Concino has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life. His collaborative efforts have resulted in the successful commercialization of several patented inventions.

Conclusion: Michael F Concino's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

This text is generated by artificial intelligence and may not be accurate.